Integrating Proteomics into Personalized Medicine for Inflammatory Bowel Disease—Reality or Challenge?
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26114993 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Horia Minea und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania. Hauptthemen laut MEDLINE: Precision Medicine, Inflammatory Bowel Diseases, Proteomics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Inflammatory bowel diseases (IBD) represent chronic conditions with etiopathogenic mechanisms incompletely elucidated despite extensive research efforts. Therefore, it is essential for clinical monitoring of the implementation of personalized medicine, enabling risk stratification and the selection of therapies with the highest likelihood of a favorable response. Multi-omics approaches have emerged as an excellent opportunity for the prevention, clinical phenotype differentiation, and prediction of IBD development. Proteomics has gained significant enthusiasm in medical practice, primarily due to its focus on studying the composition and dynamic expression of various cellular and tissue structures. This approach provides critical insights into their impact on signaling pathways, post-translational modifications, and the development of sequence variations. Hence, it could provide the foundation for developing biomarkers with the potential to assess mucosal healing and predict prognostic variability among patients, facilitating the implementation of a personalized therapeutic approach. This review focuses on the recent research regarding the possibility of implementing proteomics technologies into clinical practice, given the challenges and limitations, and the advantages of increasing the quality of life in patients with IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Grigore T. Popa University of Medicine and Pharmacy, 700115 Iasi, Romania.
- Institute of Gastroenterology and Hepatology, "St. Spiridon" University Hospital, 700111 Iasi, Romania.
- Department of Microbiology, The National Institute of Public Health, 700464 Iasi, Romania.
ORCID-Profile: Horia Minea, Ana-Maria Singeap, Stefan Andrei Chiriac, Anca Trifan
Zitieren
APA
Minea, H., Singeap, A. M., Minea, M., Juncu, S., Chiriac, S. A., Sfarti, C. V., Stanciu, C., & Trifan, A. (2025). Integrating Proteomics into Personalized Medicine for Inflammatory Bowel Disease—Reality or Challenge?. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26114993
Vancouver
Minea H, Singeap AM, Minea M, Juncu S, Chiriac SA, Sfarti CV, et al. Integrating Proteomics into Personalized Medicine for Inflammatory Bowel Disease—Reality or Challenge?. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26114993
BibTeX
@article{Minea2025,
author = {Minea, Horia and Singeap, Ana-Maria and Minea, Manuela and Juncu, Simona and Chiriac, Stefan Andrei and Sfarti, Catalin Victor and Stanciu, Carol and Trifan, Anca},
title = {Integrating Proteomics into Personalized Medicine for Inflammatory Bowel Disease—Reality or Challenge?},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26114993}
}
EUVIMED